Improvement of glucose tolerance by rhein with restored early-phase insulin secretion in db/db mice

AIMS

In the present study, we investigated whether rhein exerted hypoglycemic action and rhein's effect on the pancreatic β cell in db/db mice.

MATERIALS AND METHODS

Thirty 4-week-old db/db mice were randomized to treatment with rhein (120 mg/kg) (no.=15) and placebo (1% natrium cellulose solution) (no.=15) for 8 weeks, respectively. Fifteen age-matched non-diabetic littermates db/m mice treated with placebo were studied as non-diabetic control. After an 8-week treatment, ip glucose tolerance test (IPGTT) and arginine tolerance test were performed. Area under curve (AUC) of insulin levels in IPGTT was calculated to evaluate insulin secretory function. Immunohistochemical staining of insulin was performed to estimate β cell mass. TUNEL assay was performed to determine β cell apoptosis. Islet isolation and perifusion were performed to evaluate kinetics of insulin release in vitro, especially first-phase insulin.

RESULTS

Compared with control group, AUC of glucose concentrations significantly decreased in the rhein-treated group (p<0.05). Simultaneously, AUC of insulin levels increased in the rhein-treated group (p<0.05), especially in the first 30 min after glucose load. Perifusion showed that the rhein-treated group manifested a significantly increase of first-phase insulin secretion. Immunohistochemical study and TUNEL assay showed that rhein treatment greatly preserved β cell mass and inhibited β cell apoptosis.

CONCLUSIONS

Rhein treatment significantly improved glucose- dependent and independent insulin secretion by preservation of β cell mass and inhibition of β cell apoptosis in db/db mice. The characteristics of rhein may make it a novel therapeutic means for preventing from or curing diabetes in the near future.

SU-E-J-69: Development of an Ambiguity-Free Optical Tracking System for SBRT

PURPOSE

Commercial optical tracking system such as BrainLab ExacTrac© suffers from ambiguous markers which can cause significant delay in patient treatment. We developed an ambiguity-free optical tracking system for high precision SBRT.

METHODS

The optical tracking system consists of a pair of camera sensors, 4∼8 infra-red (IR) reflective markers affixed on patient skin and in-house developed software. We developed an effective algorithm to automatically eliminate ambiguous markers. A recursive backtracking algorithm was developed to build one-to-one correspondence between reference markers and optical markers. The algorithm was able to deal with missing, misplaced, or occluded markers by introducing 'dummy' markers. Isocenter displacements were calculated in six-degree of freedom through rigid-body registration between reference markers and optical markers. The system accuracy was evaluated with a pelvis phantom against cone beam CT (CBCT) and ExacTrac. The impact of number of markers on tracking accuracy was also evaluated. The performance of automatic ambiguity elimination was assessed with synthetic and clinic marker patterns.

RESULTS

Difference of isocenter displacement reported by our system and commercial systems (CBCT, ExacTrac) were within 0.5 mm/0.1o. Impact of number of markers on tracking accuracy in our phantom test was negligible with isocenter displacement varying within 0.2 mm/0.2o when number of markers varied from 4 to 8. The system successfully identified and eliminated ambiguous markers in both synthetic and clinic marker patterns.

CONCLUSIONS

An accurate optical tracking system free of ambiguous markers was developed for patient positioning and monitoring in high precision SBRT. The developed algorithms to eliminate ambiguous markers and to handle missing, misplaced or occluded markers were effective and efficient.

SU-D-BRCD-02: A Novel Cylindrical 3D Water Scanner for Beam Data Collection: I. Validation of the Automatic-Setup

PURPOSE

To determine the accuracy and reproducibility of the automatic- setup procedure of a 3D water scanner (3D SCANNER, Sun Nuclear Corp). The procedure automatically aligns the scanner's coordinate system to the Linac coordinate system. A unique off-center detector holder extends the scan range to 630 mm, eliminating the need for scanner shifts for large-field scans.

METHODS

The automatic-setup procedure provides means to automatically (1) level the tank; (2) zero the detector position to water surface; (3) align the scanner's coordinate system to the Linac system; and (4) correct motor hysteresis. After automatic-setup, (1) and (2) were evaluated visually by three physicists. Step (3) was tested by moving one of the jaws to the isocenter and scans were made along the jaw edge. Angular misalignment between the scanner and the Linac would Result in a noticeably tilted profile. Step (4) was tested by scanning with the chamber moving forward and then backward five times. The accuracy of the off-center detector holder was tested by comparing scans made using the regularand the off-center detector holders. All tests were repeated three times.

RESULTS

All tests of the water surface and horizontal chamber movementwere acceptable from the nine independent evaluations. Scans along the jawedge resulted in < 1% in profile tilt, corresponding to < 0.05 degree in angular misalignment. Same direction scans resulted in field edge differences < 0.05 mm, and < 0.2 mm when compared to scans in thereverse direction. There was no difference in accuracy when different scan speeds were used. Profiles obtained using the regular and the off-centerdetector holders were identical.

CONCLUSIONS

The automatic-setupprocedure resulted in accurate alignment of the 3D SCANNER to the Linac. These results were user-independent. It also provides the ability to scan large fields without the need to change tank setup. This work was partially supported by a research grant from Sun Nuclear Corp., Melbourne, FL.

Forebrain glutamatergic neurons mediate leptin action on depression-like behaviors and synaptic depression

The glutamatergic system has been implicated in the pathophysiology of depression and the mechanism of action of antidepressants. Leptin, an adipocyte-derived hormone, has antidepressant-like properties. However, the functional role of leptin receptor (Lepr) signaling in glutamatergic neurons remains to be elucidated. In this study, we generated conditional knockout mice in which the long form of Lepr was ablated selectively in glutamatergic neurons located in the forebrain structures, including the hippocampus and prefrontal cortex (Lepr cKO). Lepr cKO mice exhibit normal growth and body weight. Behavioral characterization of Lepr cKO mice reveals depression-like behavioral deficits, including anhedonia, behavioral despair, enhanced learned helplessness and social withdrawal, with no evident signs of anxiety. In addition, loss of Lepr in forebrain glutamatergic neurons facilitates NMDA-induced hippocampal long-term synaptic depression (LTD), whereas conventional LTD or long-term potentiation (LTP) was not affected. The facilitated LTD induction requires activation of the GluN2B subunit as it was completely blocked by a selective GluN2B antagonist. Moreover, Lepr cKO mice are highly sensitive to the antidepressant-like behavioral effects of the GluN2B antagonist but resistant to leptin. These results support important roles for Lepr signaling in glutamatergic neurons in regulating depression-related behaviors and modulating excitatory synaptic strength, suggesting a possible association between synaptic depression and behavioral manifestations of depression.

Autophagy promotes T-cell survival through degradation of proteins of the cell death machinery

Autophagy is implicated in regulating cell death in activated T cells, but the underlying mechanism is unclear. Here, we show that inhibition of autophagy via Beclin 1 gene deletion in T cells leads to rampant apoptosis in these cells upon TCR stimulation. Beclin 1-deficient mice fail to mount autoreactive T-cell responses and are resistant to experimental autoimmune encephalomyelitis. Compared with Th17 cells, Th1 cells are much more susceptible to cell death upon Beclin 1 deletion. Cell death proteins are highly increased in Beclin 1-deficient T cells and inhibition of caspases and genetic deletion of Bim reverse apoptosis. In addition, p62/sequestosome 1 binds to caspase-8 but does not control levels of procaspase-8 or other cell death-related proteins. These results establish a direct role of autophagy in inhibiting the programmed cell death through degradation of apoptosis proteins in activated T cells.

Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways

Dysbindin-1 regulates D2-receptor trafficking and is implicated in schizophrenia and related cognitive abnormalities, but whether this molecular effect mediates the clinical manifestations of the disorder is unknown. We explored in dysbindin-1-deficient mice (dys-/-) (1) schizophrenia-related behaviors, (2) molecular and electrophysiological changes in medial prefrontal cortex (mPFC) and (3) the dependence of these on D2-receptor stimulation. Dysbindin-1 disruption altered dopamine-related behaviors and impaired working memory under challenging/stressful conditions. Dys-/- pyramidal neurons in mPFC layers II/III were hyperexcitable at baseline but hypoexcitable following D2 stimulation. Dys-/- were also respectively more and less sensitive to D2 agonist- and antagonist-induced behavioral effects. Dys-/- had reduced expression of Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) and CaMKKβ in mPFC. Chronic D2 agonist treatment reproduced these changes in protein expression, and some of the dys-/- behavioral effects. These results elucidate dysbindin's modulation of D2-related behavior, cortical activity and mPFC CaMK components, implicating cellular and molecular mechanisms of the association of dysbindin with psychosis.

Improved glucose-stimulated insulin secretion by intra-islet inhibition of protein-tyrosine phosphatase 1B expression in rats fed a high-fat diet

BACKGROUND

Insulin resistance of pancreatic β-cell itself may be a potential link between systemic insulin resistance and impaired insulin secretion in Type 2 diabetes. Protein tyrosine phosphatase 1B (PTP1B) dephosphorylates tyrosine residues in insulin receptors (IR) and IR substrate (IRS) proteins, and thereby inhibits insulin signaling. Thus the impact of PTP1B expression on β-cell insulin pathway may affect insulin secretory function.

AIM

The aim of the present study was to investigate the effects of intra-islet inhibition of PTP1B expression on glucose-stimulated insulin secretion and potential mechanisms in rats fed a high-fat diet (HFD).

MATERIALS AND METHODS

Twenty 10-week-old Sprague Dawley rats were randomly assigned to a regular diet (RD) or a HFD for 8 weeks. At the end of the 8th week, fasting glucose, fasting insulin concentration and lipid profile were measured and an oral glucose tolerance test was done after 12-h fast. Then islet isolation was performed for static incubation and perifusion. Recombinant adenoviruses containing siPTP1B (Ad-siPTP1B), or siControl (Ad-siControl) sequences were constructed using AdEasy™ system. Islets were transfected and then assigned to the Ad-siPTP1B group, the Ad-siControl group, and mock control group. Real-time RT-PCR and Western blot were used to evaluate the expression level of PTP1B. Western blot of glucose transporter 2 (GLUT-2) and glucokinsase were also done to investigate the β-cell glucose-sensing apparatus. Islets were incubated with Krebs-Ringer bicarbonate containing 2.8 mmol/l glucose then 16.7 mmol/l glucose to evaluate glucose-stimulated insulin secretion (GSIS). Islet perifusion was also performed to evaluate kinetics of insulin release in vitro.

RESULTS

HFD rats manifested modest glucose intolerance compared with RD group. And PTP1B expression in isolated islets of rats in the HFD group was higher than that of the RD group. GSIS was impaired in islets of HFD rats (2.3±0.5-fold as basal for HFD vs 8.1±1.3-fold for RD; p<0.05). Ad-siPTP1B treatment resulted in 73% decrease in PTP1B mRNA levels and 61% decrease in PTP1B protein compared with islets treated with Ad-siControl (p<0.05). Simultaneously, PTP1B inhibition resulted in 4.7±0.8-fold increase of GSIS from basal (vs 1.9±0.1-fold for Ad-siControl, p<0.05). Perifusion showed notable improvement of first-phase insulin secretion by AdsiPTP1B treatment. Significant decrease of both GLUT-2 (by 49.8%) and glucokinase (GCK, by 43.7%) were found in the HFD group when compared with the RD group, while up-regulation of both GLUT-2 (by 98%) and GCK (by 62%) was achieved after PTP1B inhibiton by Ad-siPTP1B.

CONCLUSIONS

Intra-islet PTP1B is an important physiological regulator of glucose-induced insulin release and the characteristics of PTP1B inhibitors in insulin secretion could make it a potential novel therapeutics for protection of β-cell secretory function in Type 2 diabetes.

First Report of Leaf Spot Disease on Dictamnus dasycarpus Caused by Phoma dictamnicola in China

Fraxinella, Dictamnus dasycarpus Turcz (Rutaceae), is a perennial herbal plant and mainly distributed in Eurasia and North America. It is often used to treat jaundice, cough, rheumatism, and other diseases and is extensively cultivated in the northeast and northwest of China (3). In June 2009, a severe foliar disease was observed on D. dasycarpus in medicinal plantations in Antu, China. The disease occurred on 100% of the plants and at least 25% of the surface was affected. In the early stages of disease development, symptoms were visible on the top and bottom of infected leaves as small brown spots. Subsequently, these spots became elliptical to irregularly shaped, with beige or grayish white centers and dark brown margins. Within the spots, numerous, dark brown or black, subglobose or ostiolate pycnidia measuring 152 to 367 μm in diameter were observed. Fungal isolates were obtained from the infected leaves on potato dextrose agar (PDA) medium, with conidia that were aseptate or one-septate and ellipsoidal or reniform, measuring approximately 4.7 to 12.6 × 2.1 to 4.5 μm. On the basis of these characteristics, the fungus was identified as a Phoma sp. Four well-sporulating isolates, designated as DdPh-1, DdPh-2, DdPh-3, and DdPh-4, were selected for further studies. The morphological and cultural characteristics of these four isolates were studied as described by Boerema et al. and the fungus was identified as Phoma dictamnicola Boerema et al. (1). The internal transcribed spacer (ITS) region of the nuclear rDNA was amplified and sequenced using primers ITS4/ITS5 (2). All four of the ITS sequences were identical (GenBank Accession No. FR681861) and were 99% identical to P. dictamnicola strains CBS507.91 (Accession No. GU237877) and KACC42445 (Accession No. EF600960). Pathogenicity tests were performed by spraying the leaves of healthy D. dasycarpus plants with a conidial suspension (1 × 10⁶ conidia/ml). Five plants were inoculated with each isolate (DdPh-1, DdPh-2, DdPh-3, and DdPh-4) and five plants were mock inoculated with sterile water. The plants were covered with plastic bags and kept in a greenhouse at 20 to 25° for 72 h. After 9 to 13 days, all inoculated plants showed characteristic symptoms as previously described, while the control plants remained healthy. The fungus was reisolated from the leaf spots of inoculated plants. Currently, the economic importance of this disease is limited, but it may become a more significant problem in production of D. dasycarpus with the cultivation area increasing. The fungus was found in the Netherlands and Korea, but to our knowledge, this is the first report of P. dictamnicola on D. dasycarpus in China. References: (1) G. H. Boerema et al. Phoma Identificatión Manual: Differentiation of Specific and Infra-Specific Taxa in Culture. CABI Publishing. Wallingford, U.K., 2004. (2) D. E. L. Cooke et al. Mycol. Res. 101:667, 1997. (3) S. S. Jiang et al. Biosci. Biotechnol. Biochem. 72:660, 2008.